Published in
Nature Research, Nature Medicine, 2(27), p. 256-263, 2021
DOI: 10.1038/s41591-020-01211-7
Links
Tools
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
Journal article published in 2021 by
E. A. Rozeman,
E. P. Hoefsmit 
,
I. L. M. Reijers,
R. P. M. Saw ,
J. M. Versluis ,
O. Krijgsman,
P. Dimitriadis ,
K. Sikorska,
B. A. van de Wiel,
H. Eriksson,
M. Gonzalez,
A. Torres Acosta,
L. G. Grijpink-Ongering,
K. Shannon ,
J. B. A. G. Haanen
and other authors.
,
I. L. M. Reijers,
R. P. M. Saw ,
J. M. Versluis ,
O. Krijgsman,
P. Dimitriadis ,
K. Sikorska,
B. A. van de Wiel,
H. Eriksson,
M. Gonzalez,
A. Torres Acosta,
L. G. Grijpink-Ongering,
K. Shannon ,
J. B. A. G. Haanen
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 